Mercaptopurine

Back to search

Molecule Structure

Scientific Name

Mercaptopurine

Description of the Drug

Mercaptopurine is an antineoplastic agent used to treat acute lymphocytic leukemia.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01033

Brand Name(s)

Purinethol

Company Owner(s)

Stason Pharmaceuticals Inc, Nova Laboratories Ltd, Dr Reddys Laboratories Sa, Mylan Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221
Amidophosphoribosyltransferase SINGLE PROTEIN INHIBITOR CHEMBL2362992

Unichem Links

Atlas mercaptopurine
SureChEMBL SCHEMBL3893
PharmGKB PA450379
Human Metabolome Database HMDB0015167
DrugBank DB01033
PubChem: Thomson Pharma 14772317 15321640 15970891
PubChem 667490
Mcule MCULE-4811219863
NMRShiftDB 60062490
LINCS LSM-5963
Nikkaji J2.298E
PDBe PM6
BindingDB 50423778
EPA CompTox Dashboard DTXSID0020810
DrugCentral 1708
Brenda 1345 105222 105221 157386 46631 30171 112781 12401
Rhea 50667
ChemicalBook CB1425059 CB42610065
Guide to Pharmacology 7226
rxnorm PURIXAN MERCAPTOPURINE MERCAPTOPURINE ANHYDROUS
KEGG Ligand C01756 C02380
ChEBI 94796 50667 2208
ZINC ZINC000004658290